Alcoholic Liver Disease Flashcards

1
Q

Alcoholic liver disease

A

Chronic and excessive alcohol consumption is one of the major causes of liver disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Hepatic disease process in alcoholic liver disease

A
  1. Alcoholic fatty liver disease
  2. Alcoholic hepatitis
  3. Cirrhosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the most common manifestation of alcoholic liver disease

A

Fatty liver disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the most important risk factors for development of alcoholic liver disease?

A

Quantity and duration of alcohol intake

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

______ are more susceptible to liver disease with less alcohol intake

A

women

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Threshold for developing alcoholic liver disease

A

Men: >60-80 g/d ETOH x 10 yrs

Women: >20-40 g/d ETOH x 10 yrs

Ingestion of 160 g/d is associated with a 25 fold increased risk of developing alcoholic cirrhosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Alcoholic liver disease and chronic HCV infection

A

Chronic HCV infection is an important comorbidity

Even moderate ETOH in pt with HCV increases risk of cirrhosis and hepatocellular carcinoma

HCV and alcoholic liver disease has poorer overall survival rate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Fatty liver disease

A

Typically first sign of liver disease in patients who consume alcohol.

Microscopically, it looks like fat droplets within the cytosol of hepatocytes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Fatty liver: Sreatohepatitis

A

Inflammation as well as presence of fat cells in the liver.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Fatty liver: mallor bodies

A

aka Mallory’s hyaline

intracellular inclusion body) on biopsy.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Pts with steatohepatitis from alcohol are typically ______

A

Asymptomatic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Alcoholic liver disease: Labs

A

AST to ALT ration 2:1
Increased GGT

Could also check CBC for anemia and platelets

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Alcoholic hepatitis

A

While asymptomatic steatohepatitis due to alcohol could be referred to as “alcoholic hepatitis” the term is typically used to describe the acute onset of symptomatic hepatitis.

It is the acute onset of liver hepatitis but with alcohol being the main etiology.

Characterized by liver degeneration, spotty necrosis and fibrosis

Thought to be a precursor to cirrhosis but is still potentially reversible if they stop drinking.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Alcoholic hepatitis clinical presentation

A

Patients are typically between 40 - 50 yo with h/o heavy ETOH use (>100g/d) for > 20 years (Can also develop with h/o much shorter heavy use)

Pts often stop drinking as they become ill

Clinically acute hepatitis looks like jaundice, anorexia, fever, tender hepatomegaly/ RUQ/ epigastric pain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Alcoholic hepatitis labs

A

CBC, AST, ALT, GGT, bilirubin, albumin, PT

Rule out other causes of acute hepatitis – Anti HAV IgM, HBsAg, anti HBV core IgM, anti HCV, HCV RNA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Alcoholic hepatitis lab results

A

Moderate elevations of the AST and ALT (typically less than 300 int. unit/L, rarely higher than 500 int. unit/L)

AST: ALT ratio > 2
Elevated serum bilirubin
Elevated GGT
Leukocytosis with a predominance of neutrophils
Elevated INR/PT
17
Q

Alcoholic hepatitis diagnosis

A

Dx made based on clinical and lab features in context of long history of heavy ETOH use.

Need to look for other associated conditions due to ETOH including cardiomyopathy, skeletal muscle wasting, pancreatic dysfunction, and neurotoxicity

18
Q

Alcoholic hepatitis treatment

A

If severe, hospitalization
Abstinence from alcohol!
Can rapidly progress to hepatic failure and death.

Nutritional support
Fluid management/hydration
Use of corticosteroids is controversial but used in severe cases
pentoxifylline [Trental] inhibits tumor necrosis factor (TNF) synthesis, which is increased in patients with alcoholic hepatitis (has anti-inflammatory properties; used in severe cases)

Liver transplant in patients with advanced liver disease from alcohol (6 month abstinence and rehab program)

19
Q

Nonalcoholic fatty liver disease (NAFLD)

A
A disorder that encompasses several disorders: 
simple steatosis
steatohepatitis
fibrosis, and 
end stage liver disease (ESLD) 
in the absence of alcohol consumption
20
Q

Nonalcoholic fatty liver disease (NAFLD) risk factors

A

Female, insulin resistance, type II diabetes, central obesity, hypertension, dyslipidemia

21
Q

Nonalcoholic fatty liver disease (NAFLD) risk factors

A

From asymptomatic to advanced disease and HCC

22
Q

NAFDL history

A
significant ETOH (>2 drinks/day in men and >1 drink/day in women) must be ruled out
review of meds, OTC meds, herbals, & supplement
23
Q

NAFDL diagnosis

A

Confirmatory imaging (US)

Liver biopsy is gold standard of diagnosis: looking histologically for macrosteatosis, hepatocyte ballooning, mixed lobular inflammation

Labs: Liver enzyme elevations are usually mild and up to 80% of pts have normal liver enzymes.

24
Q

NAFDL treatment: Pharmacologic

A

These improve liver histology and function: Vitamin E, statins, metformin, TZDs (thiazolidinediones)
Correction of associated conditions (e.g., hyperlipidemia, diabetes; discontinue any hepatotoxins)

25
Q

NAFDL treatment: Nonpharmacologic

A

Weight loss and exercies

Liver transplant for advanced cirrhosis

26
Q

NAFDL prevention (prevent further damage)

A

Hep vaccines and other age appropriate immunizations
Avoid ETOH
Manage cardiovascular risk factors (see above)

27
Q

NASH monitoring

A

NASH is associated with increased risk of HCC

Annual screening with abdominal imaging and alpha fetoprotein (AFP)

28
Q

Nonalcoholic steatohepatitis (NASH)

A
Part of the spectrum of NAFLD and consists of: 
steatosis
hepatocellular ballooning
lobular inflammation, and 
fibrosis 
Risk of progression to cirrhosis
Makes up ~1/5 of NAFLD